UTI MNC Fund · Regular · Growth
NAV
₹403.1048
as of 31 Jul 2026
Expense Ratio
2.06%
AUM
₹2,192 Cr
Lumpsum returns (CAGR)
- 1Y
- +3.80%
- 3Y
- +9.27%
- 5Y
- +9.28%
- Since Inception
- +14.29%
SIP returns (XIRR)
- 1Y
- +6.03%
- 3Y
- +6.19%
- 5Y
- +8.94%
- Since Inception
- +13.50%
Returns calculated from 14 August 2018 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
What history actually did — last 10 years (Aug 2016 – Jul 2026)
A ₹5,000 monthly SIP for the last 10 years (Aug 2016 – Jul 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹10,02,613 today — ₹5,95,000 invested, 10.2% XIRR.
₹5,95,000
Invested
₹10,02,613
Value today
10.2%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Aug 2016 – Jul 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹2,55,978 today (9.9% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Aug 2016 would still hold ₹15,57,163.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹10,02,613 in this fund vs ₹12,17,407 in the benchmark — underperformance of ₹2,14,794.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Aug 2016 – Jul 2026) (22 Mar 2020) would be ₹2,79,360 today (2.79×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.02
Sharpe Ratio
+0.01
Alpha
0.25
Beta
0.02
Sortino
12.38%
Std Dev
-14.94%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 May 2026- Pharmaceuticals & Biotechnology15.98%
- Automobiles11.02%
- IT - Software8.83%
- Auto Components8.75%
- Food Products8.23%
- Industrial Products5.55%
- Diversified FMCG5.30%
- Consumer Durables4.77%
- Beverages4.19%
- Personal Products3.05%
- Electrical Equipment2.92%
- Chemicals & Petrochemicals2.68%
Each sector links to the mutual funds most exposed to it.
Thinking about UTI MNC Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
- 1Maruti Suzuki India Ltd.8.52%
- 2Nestle India Ltd.5.57%
- 3Hindustan Unilever Ltd5.30%
- 4Proctor & Gamble Health Ltd4.85%
- 5United Spirits Ltd.4.19%
- 6Gland Pharma Ltd.3.56%
- 7Crisil Ltd.2.68%
- 8Britannia Industries Ltd.2.66%
- 9Hyundai Motor India Ltd2.50%
- 10Procter & Gamble Hygiene & Hel2.46%
Investment Objective
UTI MNC Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
UTI MNC Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by UTI Mutual Fund. The fund has been operational for over 21 years. It manages assets worth ₹2,192 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE 200 TRI. The current expense ratio is 2.06%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations